POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, DECREASED CHOLESTEROL CONCENTRATION, ANTI-INFLAMMATORY AND IMMUNO-MODULATING EFFECT, AND RELEASE OF BIOACTIVE PEPTIDES INHIBITING ANGIOTENSIN-CONVERTING ENZYME Russian patent published in 2017 - IPC A61K35/747 C07K14/47 C12N1/20 A61P37/02 A61P39/06 A61P9/12 A61P9/02 A61P1/14 

FIELD: biotechnology.

SUBSTANCE: group of inventions refers to polybacterial probiotic drug including new strains of lactic acid bacteria Lactobacillus gasseri 7/12 NBIMCC No. 8720, Lactobacillus plantarum F12 NBIMCC No. 8722 and Lactobacillus helveticus A1, NBIMCC No. 8721, which has anti-inflammatory immunomodulatory, hypocholesterolemic, antioxidant and antihypertensive activity. The group of inventions also refers to the use of drug as a probiotic agent, as well as an agent which has anti-inflammatory immunomodulatory, hypocholesterolemic, antioxidant and antihypertensive activity.

EFFECT: food additives, food and functional products, pharmaceutical preparations that include this drug, have a beneficial effect on the health of people and animals.

9 cl, 8 dwg, 15 tbl